Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma. BMC Cancer. 2019 Jun 17; 19(1):593.